Old Web
English
Sign In
Acemap
>
Paper
>
JAK1/2 Inhibitor Ruxolitinib Controls a Case of Chilblain Lupus Erythematosus
JAK1/2 Inhibitor Ruxolitinib Controls a Case of Chilblain Lupus Erythematosus
2016
Joerg Wenzel
Nadine van Holt
Judith Maier
Maria Vonnahme
Thomas Bieber
Dominik Wolf
Keywords:
STAT protein
Immunology
Janus kinase
Janus kinase 1
Lupus erythematosus
stat
Ruxolitinib
Janus kinase 2
Biology
Cancer research
Chilblain lupus erythematosus
Myelofibrosis
STAT Transcription Factors
Correction
Source
Cite
Save
Machine Reading By IdeaReader
15
References
49
Citations
NaN
KQI
[]